Skip to main content
Premium Trial:

Request an Annual Quote

IBM Plans to Increase Life Science Investment in 2001

NEW YORK, Dec 18 – An IBM spokeswoman said Monday that the company intends to augment the $100 million life sciences initiative it launched in August to develop IT solutions for biotechnology, genomic, e-health, pharmaceutical, agri-science, and other life sciences industries.

While the full amount has not yet been determined, IBM spokeswoman Theo Chisholm told GenomeWeb that the company may increase the initial investment up to $100 million over the course of the year.

The funds would be directed toward “forming new partnerships and increasing the sales force in the United States and Europe,” according to Chisholm.

The additional investment “reflects our confidence in the growth of this sector,” Chisholm said.

Since August IBM has invested in technology partnerships with Incyte Genomics, First Genetic Trust, and Structural Bioinformatics.      

Earlier on Monday, the company announced that it would build a 7.5-teraflop computing cluster for NuTec Sciences of Atlanta.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.